Latest news for Green River Gold (OTC:CCRRF) Stock

Green River Gold Corp is engaged in the business of location, acquisition, exploration, and development of mineral properties, including alluvial gold properties. Its operating segments are retail division and mining division. The majority of its revenue comes from the Retail segment, which sells larger mining equipment, including refurbished used mining equipment and new equipment manufactured by a related Company.

GREEN RIVER GOLD CORP by Green River Gold Corp.

Green River Gold Corp

Entegris's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NYSE">ENTG</a>) short percent of float has fallen 15.58% since its last report. The company recently reported that it has 6.45 million shares sold short, which is 4.28% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.19 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Entegris Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734961517_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Entegris has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Entegris's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Entegris's peer group average for short interest as a percentage of float is 8.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

ENTG

Looking Into Entegris's Recent Short Interest

BHP Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>) short percent of float has fallen 4.55% since its last report. The company recently reported that it has 10.60 million shares sold short, which is 0.42% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.78 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BHP Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734961511_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BHP Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing BHP Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BHP Group's peer group average for short interest as a percentage of float is 4.64%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About BHP Group?

JMP Securities analyst Jonathan Wolleben reiterates Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Market Outperform and maintains $75 price target.

News

Price Target

Reiteration

Analyst Ratings

RYTM

JMP Securities Reiterates Market Outperform on Rhythm Pharmaceuticals, Maintains $75 Price Target

Expects to Increase Assembly Efficiency by 50%, Reducing Manual Handling, Minimizing Labor, and Enhancing Worker Safety
GARLAND, Texas, Dec. 23, 2024 /PRNewswire/ -- Massimo Group&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMO#NASDAQ">MAMO</a>) ("Massimo"), a manufacturer and distributor of powersports vehicles and pontoon boats, today announced the successful ramp-up of its new assembly line, featuring cutting-edge robotic technology designed to streamline production and enhance quality control. This investment reinforces Massimo's commitment to meeting the needs of both its customers and investors as the company prepares for an impactful 2025.

MAMO

Massimo Motor Launches New T-Boss 560L And 760L Models With Winter-Ready Features, Enhancing Production Efficiency With Advanced Robotic Technology;

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) with a Buy and maintains $46 price target.

AVXL

D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $46 Price Target

FPV Drone Infrared Lens Assemblies for European Defense Customer Expected to Drive $1.0-2.0 Million in Revenue in Calendar Year 2025
ORLANDO, Fla., Dec. 23, 2024 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4330095-1&amp;h=3171632336&amp;u=https%3A%2F%2Fwww.lightpath.com%2F&amp;a=LightPath+Technologies%2C+Inc.">LightPath Technologies, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTH#NASDAQ">LPTH</a>) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced that it has begun sustained delivery of infrared lens assemblies per the terms of the October 2024 Letter of Intent ("LOI") from a European defense customer for active duty use in first-person view (FPV) drone applications.
As part of the ongoing supply agreement LOI announced in October, LightPath is supplying custom lens assemblies using LightPath's BlackDiamond glass as well as the localization of its lens assembly manufacturing to LightPath's Latvia facility to ensure supply chain stability and reliability. While the initial order is for 1,300 assemblies, LightPath management expects that with several follow-on orders throughout calendar year 2025 in-line with targeted volume commitments, this customer could represent $1.0-2.0 million in annual revenue.

Contracts

LPTH

LightPath Technologies Begins Sustained Delivery Of Infrared Assemblies To European Defense Customer; FPV Drone Infrared Lens Assemblies For Expected To Drive $1M-2M In Revenue In 2025

Ankaa-3 features a broad hardware redesign enabling superior performance. Enhancements across the technology stack include a new cryogenic hardware design, an overhaul of the qubit circuit layout, precise qubit frequency targeting with Alternating-Bias Assisted Annealing, and flexible gate architecture with precise controls. Ankaa-3 has achieved a 99.5% median two-qubit gate fidelity.
BERKELEY, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) ("Rigetti" or the "Company"), a pioneer in full-stack quantum-classical computing, announced today the public launch of its 84-qubit Ankaa-3 system. Ankaa-3 is Rigetti's newest flagship quantum computer featuring an extensive hardware redesign that enables superior performance. Rigetti also celebrates major two-qubit gate fidelity milestones with Ankaa-3: successfully halving error rates in 2024 to achieve a median 99.0% iSWAP gate fidelity, as well as demonstrating 99.5% median fidelity fSim gates.

RGTI

Rigetti Computing Launches 84-Qubit Ankaa-3 System; Achieves 99.5% Median Two-Qubit Gate Fidelity Milestone

JMP Securities analyst Silvan Tuerkcan reiterates enGene Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENGN#NASDAQ">ENGN</a>) with a Market Outperform and maintains $18 price target.

ENGN

JMP Securities Reiterates Market Outperform on enGene Holdings, Maintains $18 Price Target

Robust October and November 2024 results driven by the continued success of FlexShopper's direct-to-consumer and business-to-business growth strategies
Based on strong October and November 2024 performance, management expects the fourth quarter of 2024 to exceed financial results for the fourth quarter of 2023
BOCA RATON, Fla., Dec. 23, 2024 (GLOBE NEWSWIRE) -- FlexShopper, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>), a prominent national online lease-to-own retailer and payment solutions provider, today announced record initial holiday season financial results, as the Company benefits from the continued success of its direct-to-consumer (DTC) and business-to-business (B2B) growth strategies. For the first two months of the 2024 fourth quarter, compared to the same two-month period in 2023, lease gross revenue increased 15%, and lease net revenue increased over 25%, as bad debt expense, as a percent of gross revenue declined by 600 basis points. As a result, lease gross profit increased 51% for the first two months of the 2024 fourth quarter, while lease marketing expense has declined over 40% for the same period. New loan originations increased over 34% versus the same two-month period last year.

Guidance

FPAY

FlexShopper Announces Record Q4 Start With Lease Gross Revenue Up 15%, Net Revenue Up 25%, And Gross Profit Up 51% YoY; Marketing Expenses Down 40%, New Loan Originations Up 34%

WIIM

HOVR

Horizon Aircraft shares are trading higher after the company received an $8.4 million investment.

Singular Genomics Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMIC#NASDAQ">OMIC</a>) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share.
The $20.00 per share represents 254% premium to the last closing share price for Singular's common stock prior to the September 12, 2024 public disclosure of Deerfield's initial acquisition proposal.

OMIC

Singular Genomics Enters Into Agreement To Be Acquired By Deerfield For $20 In Cash per Share

Castellum shares are trading lower after the company announced the pricing of a $3.6 million registered direct offering of 9.47 million shares at $0.38 per share.

Completed acquisition of strategic assets of Gander Group&#x2122;
Revenue expected to grow approximately 7.8% compared to the first nine months of 2023
Quincy, MA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Stran &amp; Company, Inc. ("Stran" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWAG#NASDAQ">SWAG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWAGW#NASDAQ">SWAGW</a>), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today reported preliminary selected unaudited results for the nine months ended September 30, 2024.
"During the quarter, we continued to execute on our growth strategy, including securing significant contracts with leading customers as well as acquiring strategic assets that complement and improve our operations," commented Andy Shape, President and CEO of Stran. "Specifically, we completed the acquisition of assets of Gander Group&#x2122;, a recognized leader in casino continuity and loyalty programs, generating over $34 million in revenue in 2023. By integrating Gander Group's assets in the gaming, casino, and entertainment sectors with our established operational infrastructure and customer base, we anticipate significant cross-selling opportunities and operational efficiencies that will drive revenue growth and improve margins. While we are working to fully integrate Gander into Stran, we project our revenue to increase by approximately 7.8% to $57 million for the nine months ended September 30, 2024 compared to the same period in 2023. Importantly, we have continued to prioritize prudent expense management, maintaining a strong balance sheet with approximately $17 million in cash equivalents and investments and no long-term debt as of September 30, 2024. The reduction in cash reflects our strategic investment in the Gander acquisition and we have no need or plan to raise capital to support our operations or ongoing growth initiatives. Lastly, we are finalizing our financial statements and look forward to sharing further updates in the coming weeks."
The selected unaudited results in this press release are preliminary and subject to the completion of accounting and interim review procedures and are therefore subject to adjustment.

Earnings

SWAG

SWAGW

Stran & Company Announces Preliminary 9-Months Ended September 30, 2024 Revenue Expected To Grow ~7.8% To To $57M YoY

Rumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>) is soaring, with shares jumping 44% pre-market after <a href="https://www.benzinga.com/24/12/42634166/rumble-stock-soars-on-775-million-investment-from-tether-what-to-know">a $775 million investment </a>from Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>).
<h2 class="wp-block-heading">Tether's Investment Boosts Rumble's Pre-Market Surge</h2>
The deal involves Tether purchasing 103.33 million shares of Rumble Class A common stock at $7.50 per share, totaling $775 million in gross proceeds. This deal marks a bold move in a sector where cryptocurrency and free speech often collide.
Rumble plans to use $250 million of the proceeds for growth initiatives, aiming to strengthen its position in the free speech video-sharing space. The remainder of the funds will be used for a self-tender offer, buying back up to 70 million shares at the same price of $7.50 each. 
CEO Chris Pavlovski emphasized the alignment between crypto and free speech.
Also Read: <a href="https://www.benzinga.com/news/global/24/12/42643821/biden-administration-initiates-trade-probe-on-chinese-legacy-chips">Biden Administration Initiates Trade Probe On Chinese &#8216;Legacy&#8217; Chips</a>
<h2 class="wp-block-heading">Rumble + Tether = Strong Partnership, Shared Values</h2>
Both Rumble and Tether share a commitment to decentralization, transparency, and free expression. Tether CEO Paolo Ardoino pointed out the increasing erosion of trust in legacy media, positioning platforms like Rumble as credible, uncensored alternatives. 
These shared values create a solid foundation for the partnership, which could transform how alternative content platforms engage with users and creators alike, he said.
<h2 class="wp-block-heading">Rumble Stock Signals Bullish, But Watch That RSI</h2>
Rumble stock is surging, fueled by the Tether investment. Its technical indicators are strongly bullish, with cautionary signs present.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23070639/Screenshot-2024-12-23-at-5.36.29-PM.png" alt="" class="wp-image-703998" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23070639/Screenshot-2024-12-23-at-5.36.29-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23070639/Screenshot-2024-12-23-at-5.36.29-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Rumble stock, at $10.32, is way above its eight-day and 20-day Simple Moving Averages (SMAs) of $8.17 and $7.76, suggesting a short-term bullish momentum. Rumble stock's 50-day and 200-day SMAs at $6.68 and $6.37 further reinforce the bullish signal in the medium to long term.
Further support for the bullish case is provided by a favorable MACD indicator of 0.53.
However, Rumble stock's Relative Strength Index sits in overbought territory at 71.96, signaling the potential for a pullback or price correction in the short term.
<h2 class="wp-block-heading">A Bold Bet For The Future Of Content</h2>
While the overbought RSI may suggest caution, momentum indicators and moving averages support a bullish outlook for Rumble stock. Tether's investment and Rumble's growth plans could further make this partnership one to watch.
With Rumble poised to capitalize on its newfound resources, investors may want to look beyond short-term volatility and focus on long-term growth.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/12/42468569/could-rumble-be-big-winner-from-trumps-ftc-commissioner-pick-been-an-invaluable-member-of-the-rumble-team">Could Rumble Be Big Winner From Trump&#8217;s FTC Commissioner Pick? &#8216;Been An Invaluable Member Of The Rumble Team&#8217;</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Social Media

Technicals

Markets

Movers

Tech

General

$USDT

Rumble Stock Soars 44% Pre-Market: Crypto Meets Free Speech — Game-Changer Or Hype?

Rigetti Computing shares are trading higher. The company announced it has launched its 84-Qubit Ankaa 3 System and achieved 99.5% Median Two-Qubit Gate Fidelity Milestone.

Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) gains significant leverage in future litigation after <a href="https://www.benzinga.com/24/12/42633922/qualcomm-bags-win-in-chips-licensing-trial-against-arm-but-the-battle-is-not-over-yet">securing a critical legal win</a> against Arm Holdings Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), according to JPMorgan analyst Samik Chatterjee.
What The Court Said: A Delaware District Court ruled that Qualcomm's acquisition of Nuvia did not violate Arm's Architecture License Agreement (ALA), securing the designs under Qualcomm's license. 
While the verdict didn't resolve all questions about Nuvia's prior actions, it eliminates fears of canceled licenses or disruptive financial repercussions.
It also dismisses major uncertainties surrounding the license agreement with Arm and allows San Diego-based Qualcomm to continue selling and innovating on Arm&#8217;s chips without interruption.
Still, Chatterjee warns of potential future litigation from Arm and hints at possible renegotiations over financial terms for ALA extensions beyond 2033. Qualcomm has the option to renew the license for an additional five years in 2028 for just $1 million annually—a move that could be pivotal for its long-term roadmap.
Read More: <a href="https://www.benzinga.com/24/12/42633922/qualcomm-bags-win-in-chips-licensing-trial-against-arm-but-the-battle-is-not-over-yet">Qualcomm Bags Win In Chips Licensing Trial Against Arm, But The Battle Is Not Over Yet</a>
Beyond The Courtroom: Trial disclosures revealed Qualcomm's ambitious plans post-Nuvia acquisition, including four groundbreaking CPU design efforts:
<ul>
<li>Hamoa – Aimed at PCs and laptops.</li>
<li>Pakala – Targeting the smartphone market.</li>
<li>Nordschleife – Designed for automotive applications.</li>
<li>Pegasus – Focused on future computing and mobile innovations.</li>
</ul>
<ol></ol>
While these efforts showcase Qualcomm's R&amp;D prowess, Arm's potential plans to develop its own processors — possibly for Samsung — add an intriguing layer of competition.
<h2 class="wp-block-heading">Bearish Signals Dominate</h2>
Despite the legal victory, Qualcomm's stock isn't getting much love from the technical indicators. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23052409/Screenshot-2024-12-23-at-3.53.42-PM.png" alt="" class="wp-image-703803" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23052409/Screenshot-2024-12-23-at-3.53.42-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23052409/Screenshot-2024-12-23-at-3.53.42-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Trading at $152.89, QCOM stock lags below its eight-day, 20-day, 50-day, and 200-day simple moving averages—all flashing bearish signals. 
The Moving Average Convergence Divergence (MACD) at a negative 2.73 and a Relative Strength Index (RSI) of 39.6 suggest QCOM stock is nearing oversold territory, but bears remain in control.
Chatterjee maintains an &#8216;Overweight&#8217; rating for Qualcomm stock, citing its ability to navigate legal challenges and drive innovation. 
However, the road ahead could see bumps if Arm chooses to escalate disputes or Qualcomm faces challenges in renegotiating license terms.
For Qualcomm investors, the court ruling removes a major overhang, clearing the way for further innovation in Arm-based chips. 
Yet, with bearish technicals and lingering uncertainties about Arm's next moves, the stock remains a high-stakes play.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42621868/nvidia-secures-eu-approval-for-runai-deal-us-probes-china-export-breach">Nvidia Secures EU Approval For Run:ai Deal, US Probes China Export Breach</a></li>
</ul>
Image: Shutterstock

Analyst Color

Government

Long Ideas

Regulations

Legal

QCOM

Qualcomm Scores Big In Arm Lawsuit: Will Bearish Trends Back Down?

WVE-007 is a novel approach for treating obesity and is designed to silence INHBE to achieve healthy, sustainable weight loss through fat burning, muscle maintenance and the potential for once or twice-annual administration
WVE-007 is Wave's first siRNA program to enter clinical development and uses best-in-class oligonucleotide chemistry and GalNAc delivery
Wave expects to initiate the first-in-human study of WVE-007 in 1Q 2025
CAMBRIDGE, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the submission of its first clinical trial application (CTA) for WVE-007 in obesity. WVE-007 is an investigational GalNAc-conjugated small interfering RNA (siRNA) designed to silence Inhibin&nbsp;βE (INHBE) gene expression, which would induce fat burning (lipolysis) to decrease body weight without impacting muscle mass. Wave expects CTA approval and initiation of the first-in-human study of WVE-007 in the first quarter of 2025.

Biotech

Wave Life Sciences Announces Submission Of First Clinical Trial Application For WVE-007 In Obesity

Keybanc analyst Tim Rezvan maintains BKV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKV#NYSE">BKV</a>) with a Overweight and raises the price target from $23 to $25.

Keybanc Maintains Overweight on BKV, Raises Price Target to $25

Rumble shares are trading higher after the company announced it has entered into a definitive agreement for a strategic investment of $775 million from Tether.

As of Dec. 23, 2024, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Profire Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFIE#NASDAQ">PFIE</a>)</h3>
<ul>
<li>On Nov. 6, Profire Energy posted in-line quarterly earnings. The company's stock surged around 79% over the past six months and has a <a href="https://www.benzinga.com/quote/PFIE">52-week high of $2.55</a>.</li>
<li>RSI Value: 70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>PFIE Price Action: Shares of Profire Energy closed at $2.54 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Adams Resources &amp; Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AE#NYSE">AE</a>)</h3>
<ul>
<li>On Nov. 12, Adams Resources &amp; Energy posted better-than-expected quarterly sales. &#8220;We are encouraged by the increase in Adjusted EBITDA from crude oil marketing operations, as higher oil prices compared to the prior-year quarter more than offset the lower volumes related to our exit of the Red River operations in the fourth quarter of 2023,&#8221; said Kevin Roycraft, President and CEO of the Company. The company's stock gained around 52% over the past six months and <a href="https://www.benzinga.com/quote/AE">has a 52-week high</a> of $37.90.</li>
<li>RSI Value: 76</li>
<li>AE Price Action: Shares of Adams Resources &amp; Energy closed at $37.30 on Friday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></li>
</ul>

Pre-Market Outlook

PFIE

Top 2 Energy Stocks That May Dip This Quarter

Press Releases

Green River Gold Corp. Commences Placer Gold Mining on the Wabi Claim Located on the Swift River

Green River Gold Corp. Provides Update on Its Wabi Placer Mining Project

Green River Gold Corp. Announces The Launch Of A Non-Brokered Private Placement Offering Of Convertible Debentures And The Final Closing Of Its Non-Brokered Private Placement Of Units Consisting Of Flow-Through Shares And Warrants

Comments

Green River Gold

News

Latest news for Green River Gold (OTC:CCRRF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga